Podcast: Complement and Neonatal Fc receptor inhibitors in myasthenia gravis, highlighting CHAMPION MG (ravulizumab) and ADAPT (efgartigimod) trials

12/13/2022 - Dr. Elie Naddaf, MD interviews Dr. James Howard, MD about the use of complement and the neonatal Fc receptor inhibitors in myasthenia gravis, highlighting CHAMPION MG (ravulizumab) and ADAPT (efgartigimod) trials. 1 hour 6 minutes

Summary


Availability:	On-Demand


Cost:	FREE


Credit Offered:	No Credit Offered